Quintiles Transnational Holdings Aktie [WKN DE: A1T788 / ISIN: US74876Y1010]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Quintiles Transnational Holdings INC

29.01.19		IQVIA Institute for Human Data Science Study: Global Medicine Spending Exceeds $1.5 Trillion by 2023 as Spending Growth Steadies (Businesswire)
22.01.19		IQVIA Named to FORTUNE’s 2019 List of "World’s Most Admired Companies” (Businesswire)
08.01.19		IQVIA Announces Comprehensive Multi-Tenant SaaS Safety Platform for Life Sciences Industry (Businesswire)
07.01.19		IQVIA’s Orchestrated Customer Engagement (OCE) Solution Adopted by More than 30 Life Sciences Companies in First Year of Launch (Businesswire)
06.12.18		IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards (Businesswire)
30.11.18		IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
29.11.18		IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
29.11.18		IQVIA’s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency (Businesswire)
27.11.18		IQVIA’s Orchestrated Customer Engagement Selected by Novo Nordisk International Operations (Businesswire)
20.11.18		Adhera Therapeutics Selects IQVIA’s OCE Technology Platform to Support Commercial Excellence (Businesswire)
15.11.18		IQVIA Launches Digital ICF Author, a SaaS eConsent Tool to Transform the Informed Consent Process (Businesswire)
06.11.18		IQVIA to Present at the Credit Suisse Annual Healthcare Conference on November 13, 2018 (Businesswire)
22.10.18		IQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance (Businesswire)
16.10.18		IQVIA’s Commercial Technology Suite for Global Deployment Selected by Roche (Businesswire)
15.10.18		IQVIA to Announce Third-Quarter 2018 Results on October 22, 2018 (Businesswire)
04.10.18		IQVIA and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data (Businesswire)
20.09.18		IQVIA to Build Clinically-Focused Tech Solutions Suite for Life Sciences on Salesforce Health Cloud (Businesswire)
16.08.18		Theramex Chooses IQVIA’s Orchestrated Customer Engagement (Businesswire)
02.08.18		Medytox Selects IQVIA’s Enterprise Quality Management Platform, Including SmartSolve®, for Quality and Compliance Management (Businesswire)
01.08.18		IQVIA’s Jon Resnick Honored on 2018 PharmaVOICE 100 List (Businesswire)
10.07.18		IQVIA to Announce Second-Quarter 2018 Results on July 24, 2018 (Businesswire)
21.06.18		IQVIA Launches a Transformative Suite of Virtual Research Solutions (Businesswire)
13.06.18		IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
12.06.18		IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
12.06.18		IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness (Businesswire)
05.06.18		IQVIA Launches Commercial Content Management Solution IQVIA™ ePromo (Businesswire)
24.05.18		IQVIA™ Institute for Human Data Science Study: Spending on Cancer Meds in the U.S. Doubled from 2012-2017 – Expected to Double Again by 2022 to $100 Billion (Businesswire)
18.05.18		PruGen Pharmaceuticals Selects IQVIA’s OCE Technology Platform to Advance Field Sales and Home Office Effectiveness (Businesswire)
18.05.18		IQVIA Reaffirms Its Second-Quarter and Full-Year 2018 Guidance, Including Adjusted EPS Growth of 13.6% to 20.4% and 14.3% to 19.9%, Respectively (Businesswire)
18.05.18		IQVIA Holdings Inc. Provides Update on Secondary Offering (Businesswire)
16.05.18		IQVIA Response to FDA Statement (Businesswire)
16.05.18		IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
15.05.18		IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
08.05.18		IQVIA to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 (Businesswire)
02.05.18		IQVIA Reports First-Quarter 2018 Results and Raises Full-Year 2018 Revenue Guidance (Businesswire)
30.04.18		Recordati Selects IQVIA’s OCE Technology Platform and OneKey Information Services (Businesswire)
24.04.18		Kiwi Energy Sponsors Transportation Alternatives Bike Month (PR Newswire)
19.04.18		IQVIA™ Institute for Human Data Science Study: U.S. Prescription Opioid Volume Declined 12 Percent in 2017 – Largest Drop in 25 Years (Businesswire)
18.04.18		IQVIA to Announce First-Quarter 2018 Results on May 2, 2018 (Businesswire)
15.03.18		IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies (Businesswire)
14.03.18		IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries (Businesswire)
13.03.18		IQVIA Institute for Human Data Science Study: 10 Predictions for Innovation, Spending Drivers and Societal Value of Medicines that Will Transform Global Healthcare in 2018 and Beyond (Businesswire)
14.02.18		IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance (Businesswire)
06.02.18		IQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and Research (Businesswire)
19.01.18		IQVIA Named to FORTUNE’s 2018 List of "World’s Most Admired Companies” (Businesswire)
12.12.17		IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement (Businesswire)
12.12.17		IQVIA Launches Orchestrated Customer Engagement (Businesswire)
28.11.17		IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
27.11.17		IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
07.11.17		IQVIA Institute for Human Data Science Study: Impact of Digital Health Grows as Innovation, Evidence and Adoption of Mobile Health Apps Accelerate (Businesswire)

Erste Seite Zurück | ... | 2 | 3 | 4 | 5 | Weiter

Newssuche

Meistgelesene Nachrichten

Mit Ripple Millionär werden? So klappt’s!

Pierer Mobility-Aktie schwach: Gehälter für Angestellte von insolventer KTM noch vor Weihnachten

Ethereum Kurs Prognose: ETH massiv unterbewertet! Fällt jetzt das ATH?

UNIQA Insurance-Aktie im Plus: UNIQA plant zu expandieren und Dividenden zu erhöhen

Bundesheer wirbt nach KTM-Insolvenz um Mitarbeiter - Pierer Mobility-Aktie im Plus

Stühlerücken im NASDAQ 100: MicroStrategy- und Palantir-Aktie kommen, Super Micro-Aktie verlässt Index

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	15.12.2024 13:28
Kaufwert:	EUR
	Hinzufügen Speichern